Virtual Incision

Executive Summary

Virtual Incision is a US-based medical device company pioneering Miniaturized Robotic-Assisted Surgery (miniRAS) with its MIRA Surgical System. Unlike traditional robotic systems that are large, expensive, and require dedicated OR space, MIRA is compact, portable, and designed to integrate into existing hospital infrastructure. This innovation aims to expand access to robotic surgery by enabling use in community hospitals, ambulatory surgery centers, and even battlefield or remote settings. Founded in 2006 and headquartered in Lincoln, Nebraska, the company targets the significant unmet need for affordable, scalable robotic surgery platforms. MIRA has the potential to disrupt the da Vinci-dominated market by offering a lower-cost, more versatile alternative. The company has demonstrated progress with initial clinical studies and has secured strategic partnerships to support manufacturing and distribution. Virtual Incision is actively pursuing regulatory approvals, with FDA clearance for MIRA in certain indications anticipated in the near term. A successful launch could unlock a multi-billion-dollar opportunity in the minimally invasive surgery market. The company's conviction score reflects strong clinical promise, a differentiated product, and favorable market tailwinds, tempered by regulatory and commercial execution risks.

Upcoming Catalysts (preview)

• Q3 2026FDA Clearance for MIRA Surgical System in General Surgery Indications65% success
• Q4 2026First Commercial Installation and Revenue Generation in U.S.55% success
• TBDStrategic Partnership or Distribution Agreement for International Markets60% success